Resveratrol reverts Streptozotocin-induced diabetic nephropathy

被引：15
|
作者：
Zhu, Huiping [1 ,2 ]
Zhong, Sen [1 ,2 ]
Yan, Haihong [1 ,2 ]
Wang, Kangyao [1 ,2 ]
Chen, Lingwei [1 ,2 ]
Zhou, Min [1 ,2 ]
Li, Yunsheng [1 ,2 ]
机构：
[1] Wenzhou Med Univ, Peoples Hosp Wenling 1, Dept Nephrol, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Wenling Hosp, 333 Chuanan Rd, Wenling 317500, Zhejiang, Peoples R China
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2020年 / 25卷
关键词：
Resveratrol; Renal dysfunction; Diabetic nephropathy; mTOR/ULK1; pathway; Autophagy; RENAL LIPID-METABOLISM; PODOCYTE FUNCTION; AUTOPHAGY; MICE; ACCUMULATION; PROGRESSION; PROTECTS; FIBROSIS; TARGET; MTOR;
D O I：
10.2741/4829
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Diabetes causes diabetic nephropathy (DN) which is associated with increased morbidity and mortality in diabetic patients. We tested whether Resveratrol (Res) reverses the systemic effect of Streptozotocin (STZ) induced diabetes and DN. Res treatment opposed the effect of STZ on kidney weight, 24 h urinary albumin excretion, blood urea nitrogen (BUN) and serum creatinine (Scr). Res also decreased DN induced mTOR/ULK1-mediated autophagy and apoptosis and significantly reduced STZ mediated lipid deposition in nephrons, likely by decreasing the levels of lipogenic related proteins (SREBP-1c, ACS) and increased lipidolysis related proteins (PPAR alpha, CPT-1). Together, these findings show the potential of Res in prevention of diabetic nephropathy.
引用
收藏
页码：699 / 709
页数：11
相关论文
共 50 条
  • [31] The ameliorative potential of Hyphaene thebaica on streptozotocin-induced diabetic nephropathy
    AbdEl-moniem, M.
    Mustafa, H. N.
    Megahed, H. A.
    Agaibyi, M. H.
    Hegazy, G. A.
    El-Dabaa, M. A.
    FOLIA MORPHOLOGICA, 2015, 74 (04) : 447 - 457
  • [32] Pterostilbene Ameliorates Nephropathy Injury in Streptozotocin-Induced Diabetic Rats
    Zhang, Ying
    Ren, Shaoyu
    Ji, Ying
    Liang, Yafeng
    PHARMACOLOGY, 2019, 104 (1-2) : 71 - 80
  • [33] Synergistic Effects of Leflunomide and Benazepril in Streptozotocin-Induced Diabetic Nephropathy
    Jin, Hua
    Piao, Shang Guo
    Jin, Ji Zhe
    Jin, Ying Shun
    Cui, Zhen Hua
    Jin, Hai Feng
    Zheng, Hai Lan
    Li, Jin Ji
    Jiang, Yu Ji
    Yang, Chul Woo
    Li, Can
    NEPHRON EXPERIMENTAL NEPHROLOGY, 2014, 126 (03): : 148 - 156
  • [34] Protective effects of Croton hookeri on streptozotocin-induced diabetic nephropathy
    Kundu, Amit
    Dey, Prasanta
    Sarkar, Pradipta
    Karmakar, Sanmoy
    Tae, In Hwan
    Kim, Kyeong Seok
    Park, Jae Hyeon
    Lee, Su Hyun
    Lee, Byung Mu
    Renthlei, Lalmuanawmi
    Puia, Zothan
    Kim, Hyung Sik
    FOOD AND CHEMICAL TOXICOLOGY, 2020, 135
  • [35] The role of oxidative stress in streptozotocin-induced diabetic nephropathy in rats
    Fernandes, Sheila Marques
    Cordeiro, Priscilla Mendes
    Watanabe, Mirian
    da Fonseca, Cassiane Dezoti
    Fernandes Vattimo, Maria de Fatima
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2016, 60 (05): : 443 - 449
  • [36] Streptozotocin-induced diabetic nephropathy in rats: The role of inflammatory cytokines
    Mensah-Brown, EPK
    Obineche, EN
    Galadari, S
    Chandranath, E
    Shahin, A
    Ahmed, I
    Patel, SM
    Adem, A
    CYTOKINE, 2005, 31 (03) : 180 - 190
  • [37] The Protective Effect of Fucoidan in Rats with Streptozotocin-Induced Diabetic Nephropathy
    Wang, Jing
    Liu, Huaide
    Li, Ning
    Zhang, Quanbin
    Zhang, Hong
    MARINE DRUGS, 2014, 12 (06): : 3292 - 3306
  • [38] L-DOPA AND STREPTOZOTOCIN-INDUCED DIABETIC NEPHROPATHY IN RATS
    BARTHELMEBS, M
    VAILLY, B
    VELLY, J
    GRIMA, M
    IMBS, JL
    AMERICAN JOURNAL OF HYPERTENSION, 1990, 3 (06) : S72 - S74
  • [39] Effect of Bilirubin on Triglyceride Synthesis in Streptozotocin-Induced Diabetic Nephropathy
    Xu, Jianwei
    Lee, Eun Seong
    Baek, Seon Ha
    Ahn, Shin-Young
    Kim, Sejoong
    Na, Ki Young
    Chae, Dong-Wan
    Chin, Ho Jun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 : S155 - S163
  • [40] Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats
    Ates, Ozkan
    Cayli, Suleyman R.
    Yucel, Neslihan
    Altinoz, Eyup
    Kocak, Ayhan
    Durak, M. Akif
    Turkoz, Yusuf
    Yologlu, Saim
    JOURNAL OF CLINICAL NEUROSCIENCE, 2007, 14 (03) : 256 - 260
12345